Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 519

1.

Cardiac Computed Tomography for Atrial Fibrillation Patients Undergoing Ablation: Implications for the Prediction of Early Recurrence.

Ebersberger U, Bernard ML, Schoepf UJ, Wince WB, Litwin SE, Wang Y, Blanke P, Makowski MR, McQuiston AD, Silverman JR, Gray JC, Tesche C, Duguay TM, Schmidt M, Wharton JM, Bayer RR 2nd.

J Thorac Imaging. 2019 May 27. doi: 10.1097/RTI.0000000000000425. [Epub ahead of print]

PMID:
31145188
2.

Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis.

Sofianopoulou E, Kaptoge S, Gräf S, Hadinnapola C, Treacy CM, Church C, Coghlan G, Gibbs JSR, Haimel M, Howard LS, Johnson M, Kiely DG, Lawrie A, Lordan J, MacKenzie Ross RV, Martin JM, Moledina S, Newnham M, Peacock AJ, Price LC, Rhodes CJ, Suntharalingam J, Swietlik EM, Toshner MR, Wharton J, Wilkins MR, Wort SJ, Pepke-Zaba J, Condliffe R, Corris PA, Di Angelantonio E, Provencher S, Morrell NW.

Eur Respir J. 2019 May 30;53(5). pii: 1801429. doi: 10.1183/13993003.01429-2018. Print 2019 May.

PMID:
30923185
3.

Accuracy of a composite event definition for hypoglycemia.

Min JY, Presley CA, Wharton J, Griffin MR, Greevy RA Jr, Hung AM, Chipman J, Grijalva CG, Hackstadt AJ, Roumie CL.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):625-631. doi: 10.1002/pds.4712. Epub 2019 Mar 6.

PMID:
30843332
4.

Prophylactic pulmonary vein isolation during cavotricuspid isthmus ablation for atrial flutter: A meta-analysis.

Koerber SM, Turagam MK, Gautam S, Winterfield J, Wharton JM, Lakkireddy D, Gold MR.

Pacing Clin Electrophysiol. 2019 May;42(5):493-498. doi: 10.1111/pace.13637. Epub 2019 Mar 18.

PMID:
30779174
5.

The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.

Newnham M, South K, Bleda M, Auger WR, Barberà JA, Bogaard H, Bunclark K, Cannon JE, Delcroix M, Hadinnapola C, Howard LS, Jenkins D, Mayer E, Ng C, Rhodes CJ, Screaton N, Sheares K, Simpson MA, Southwood M, Su L, Taboada D, Traylor M, Trembath RC, Villar SS, Wilkins MR, Wharton J, Gräf S, Pepke-Zaba J, Laffan M, Lane DA, Morrell NW, Toshner M.

Eur Respir J. 2019 Mar 28;53(3). pii: 1801805. doi: 10.1183/13993003.01805-2018. Print 2019 Mar.

6.

Human PAH is characterized by a pattern of lipid-related insulin resistance.

Hemnes AR, Luther JM, Rhodes CJ, Burgess JP, Carlson J, Fan R, Fessel JP, Fortune N, Gerszten RE, Halliday SJ, Hekmat R, Howard L, Newman JH, Niswender KD, Pugh ME, Robbins IM, Sheng Q, Shibao CA, Shyr Y, Sumner S, Talati M, Wharton J, Wilkins MR, Ye F, Yu C, West J, Brittain EL.

JCI Insight. 2019 Jan 10;4(1). pii: 123611. doi: 10.1172/jci.insight.123611. [Epub ahead of print]

7.

Metabolic pathways associated with right ventricular adaptation to pulmonary hypertension: 3D analysis of cardiac magnetic resonance imaging.

Attard MI, Dawes TJW, de Marvao A, Biffi C, Shi W, Wharton J, Rhodes CJ, Ghataorhe P, Gibbs JSR, Howard LSGE, Rueckert D, Wilkins MR, O'Regan DP.

Eur Heart J Cardiovasc Imaging. 2019 Jun 1;20(6):668-676. doi: 10.1093/ehjci/jey175.

8.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.

9.

Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension.

Harbaum L, Ghataorhe P, Wharton J, Jiménez B, Howard LSG, Gibbs JSR, Nicholson JK, Rhodes CJ, Wilkins MR.

Thorax. 2019 Apr;74(4):380-389. doi: 10.1136/thoraxjnl-2018-212144. Epub 2018 Nov 26.

10.

3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.

Ashek A, Spruijt OA, Harms HJ, Lammertsma AA, Cupitt J, Dubois O, Wharton J, Dabral S, Pullamsetti SS, Huisman MC, Frings V, Boellaard R, de Man FS, Botros L, Jansen S, Vonk Noordegraaf A, Wilkins MR, Bogaard HJ, Zhao L.

Circ Cardiovasc Imaging. 2018 Aug;11(8):e007402. doi: 10.1161/CIRCIMAGING.117.007402.

11.

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.

Bohnen MS, Ma L, Zhu N, Qi H, McClenaghan C, Gonzaga-Jauregui C, Dewey FE, Overton JD, Reid JG, Shuldiner AR, Baras A, Sampson KJ, Bleda M, Hadinnapola C, Haimel M, Bogaard HJ, Church C, Coghlan G, Corris PA, Eyries M, Gibbs JSR, Girerd B, Houweling AC, Humbert M, Guignabert C, Kiely DG, Lawrie A, MacKenzie Ross RV, Martin JM, Montani D, Peacock AJ, Pepke-Zaba J, Soubrier F, Suntharalingam J, Toshner M, Treacy CM, Trembath RC, Vonk Noordegraaf A, Wharton J, Wilkins MR, Wort SJ, Yates K, Gräf S, Morrell NW, Krishnan U, Rosenzweig EB, Shen Y, Nichols CG, Kass RS, Chung WK.

Circ Genom Precis Med. 2018 Oct;11(10):e002087. doi: 10.1161/CIRCGEN.118.002087.

12.

Recent advances in pulmonary arterial hypertension.

Wilkins MR, Aman J, Harbaum L, Ulrich A, Wharton J, Rhodes CJ.

F1000Res. 2018 Jul 24;7. pii: F1000 Faculty Rev-1128. doi: 10.12688/f1000research.14984.1. eCollection 2018. Review.

13.

Absence of sustained breast cancer incidence inflation in a national mammography screening programme.

Morrell S, Gregory M, Sexton K, Wharton J, Sharma N, Taylor R.

J Med Screen. 2019 Mar;26(1):26-34. doi: 10.1177/0969141318775766. Epub 2018 Jun 27.

PMID:
29950138
14.

Breast cancer mortality and screening mammography in New Zealand: Incidence-based and aggregate analyses.

Taylor R, Gregory M, Sexton K, Wharton J, Sharma N, Amoyal G, Morrell S.

J Med Screen. 2019 Mar;26(1):35-43. doi: 10.1177/0969141318776039. Epub 2018 Jun 12.

PMID:
29895225
15.

Fractal Analysis of Right Ventricular Trabeculae in Pulmonary Hypertension.

Dawes TJW, Cai J, Quinlan M, de Marvao A, Ostrowski PJ, Tokarczuk PF, Watson GMJ, Wharton J, Howard LSGE, Gibbs JSR, Cook SA, Wilkins MR, O'Regan DP.

Radiology. 2018 Aug;288(2):386-395. doi: 10.1148/radiol.2018172821. Epub 2018 Jun 5.

16.

Biofilm Inhibition by Novel Natural Product- and Biocide-Containing Coatings Using High-Throughput Screening.

Salta M, Dennington SP, Wharton JA.

Int J Mol Sci. 2018 May 10;19(5). pii: E1434. doi: 10.3390/ijms19051434.

17.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

18.

High-dose Chemotherapy is Efficacious and Well Tolerated in a Toddler With Aicardi Syndrome and Malignant Sacrococcygeal Teratoma.

Wharton JD, Johnson S, Connelly JA, Hills T, Gingles L, Wood M, Crane GL, Katzenstein HM.

J Pediatr Hematol Oncol. 2018 Oct;40(7):e467-e469. doi: 10.1097/MPH.0000000000001091.

PMID:
29420371
19.

Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.

Michelakis ED, Gurtu V, Webster L, Barnes G, Watson G, Howard L, Cupitt J, Paterson I, Thompson RB, Chow K, O'Regan DP, Zhao L, Wharton J, Kiely DG, Kinnaird A, Boukouris AE, White C, Nagendran J, Freed DH, Wort SJ, Gibbs JSR, Wilkins MR.

Sci Transl Med. 2017 Oct 25;9(413). pii: eaao4583. doi: 10.1126/scitranslmed.aao4583.

20.

Sharks in Captivity: The Role of Husbandry, Breeding, Education, and Citizen Science in Shark Conservation.

Grassmann M, McNeil B, Wharton J.

Adv Mar Biol. 2017;78:89-119. doi: 10.1016/bs.amb.2017.08.002. Epub 2017 Sep 15.

PMID:
29056144
21.

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.

Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, Preston SD, Southwood M, Hernandez-Sanchez J, Martin J, Treacy C, Yates K, Bogaard H, Church C, Coghlan G, Condliffe R, Corris PA, Gibbs S, Girerd B, Holden S, Humbert M, Kiely DG, Lawrie A, Machado R, MacKenzie Ross R, Moledina S, Montani D, Newnham M, Peacock A, Pepke-Zaba J, Rayner-Matthews P, Shamardina O, Soubrier F, Southgate L, Suntharalingam J, Toshner M, Trembath R, Vonk Noordegraaf A, Wilkins MR, Wort SJ, Wharton J; NIHR BioResource–Rare Diseases Consortium; UK National Cohort Study of Idiopathic and Heritable PAH, Gräf S, Morrell NW.

Circulation. 2017 Nov 21;136(21):2022-2033. doi: 10.1161/CIRCULATIONAHA.117.028351. Epub 2017 Sep 28.

22.

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.

Rhodes CJ, Wharton J, Ghataorhe P, Watson G, Girerd B, Howard LS, Gibbs JSR, Condliffe R, Elliot CA, Kiely DG, Simonneau G, Montani D, Sitbon O, Gall H, Schermuly RT, Ghofrani HA, Lawrie A, Humbert M, Wilkins MR.

Lancet Respir Med. 2017 Sep;5(9):717-726. doi: 10.1016/S2213-2600(17)30161-3. Epub 2017 Jun 15.

23.

Water depth effects on impact loading, kinematic and physiological variables during water treadmill running.

Macdermid PW, Wharton J, Schill C, Fink PW.

Gait Posture. 2017 Jul;56:108-111. doi: 10.1016/j.gaitpost.2017.05.013. Epub 2017 May 17.

PMID:
28535432
24.

Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.

Ghataorhe P, Rhodes CJ, Harbaum L, Attard M, Wharton J, Wilkins MR.

J Intern Med. 2017 Aug;282(2):129-141. doi: 10.1111/joim.12623. Epub 2017 May 19. Review.

25.

Machine Learning of Three-dimensional Right Ventricular Motion Enables Outcome Prediction in Pulmonary Hypertension: A Cardiac MR Imaging Study.

Dawes TJW, de Marvao A, Shi W, Fletcher T, Watson GMJ, Wharton J, Rhodes CJ, Howard LSGE, Gibbs JSR, Rueckert D, Cook SA, Wilkins MR, O'Regan DP.

Radiology. 2017 May;283(2):381-390. doi: 10.1148/radiol.2016161315. Epub 2017 Jan 16.

26.

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.

Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, Watson G, Bleda M, Haimel M, Coghlan G, Corris PA, Howard LS, Kiely DG, Peacock AJ, Pepke-Zaba J, Toshner MR, Wort SJ, Gibbs JS, Lawrie A, Gräf S, Morrell NW, Wilkins MR.

Circulation. 2017 Jan 31;135(5):460-475. doi: 10.1161/CIRCULATIONAHA.116.024602. Epub 2016 Nov 21.

27.

Sotalol.

Kpaeyeh JA Jr, Wharton JM.

Card Electrophysiol Clin. 2016 Jun;8(2):437-52. doi: 10.1016/j.ccep.2016.02.007. Review.

PMID:
27261833
28.
29.

Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future.

Lythgoe MP, Rhodes CJ, Ghataorhe P, Attard M, Wharton J, Wilkins MR.

Pharmacol Ther. 2016 Aug;164:195-203. doi: 10.1016/j.pharmthera.2016.04.012. Epub 2016 Apr 29. Review.

30.

Endothelium-derived microparticles from chronically thromboembolic pulmonary hypertensive patients facilitate endothelial angiogenesis.

Belik D, Tsang H, Wharton J, Howard L, Bernabeu C, Wojciak-Stothard B.

J Biomed Sci. 2016 Jan 19;23:4. doi: 10.1186/s12929-016-0224-9.

31.

Delayed Unilateral Adrenal Hemorrhage Complicating Pneumococcal Septic Shock.

Wharton J, Cohen D.

Del Med J. 2015 Oct;87(10):310-2.

PMID:
26638422
32.

Corrosion control: general discussion.

Cook A, Frankel G, Davenport A, Hughes T, Gibbon S, Williams D, Bluhm H, Maurice V, Lyth S, Marcus P, Shoesmith D, Wren C, Wharton J, Hunt G, Lyon S, Majchrowski T, Lindsay R, Williams G, Rico Oller B, Todorova M, Nixon S, Cheng ST, Scully J, Wilson A, Renner F, Chen YH, Taylor C, Habazaki H, Michaelides A, Morsch S, Visser P, Kyhl L, Kokalj A.

Faraday Discuss. 2015;180:543-76. doi: 10.1039/c5fd90047f. No abstract available.

PMID:
26134287
33.

Corrosion scales and passive films: general discussion.

Frankel G, Mauzeroll J, Thornton G, Bluhm H, Morrison J, Maurice V, Rayment T, Williams D, Cook A, Joshi G, Davenport A, Gibbon S, Kramer D, Acres M, Tautschnig M, Habazaki H, Marcus P, Shoesmith D, Wren C, Majchrowski T, Lindsay R, Wood M, Todorova M, Scully J, Renner F, Kokalj A, Taylor C, Virtanen S, Wharton J.

Faraday Discuss. 2015;180:205-32. doi: 10.1039/c5fd90045j. Epub 2015 Jul 2. No abstract available.

PMID:
26134146
34.

Mechano-electrochemistry effects due to deformation of copper oxide films.

Kramer D, Wang Y, Wharton J.

Faraday Discuss. 2015;180:137-49. doi: 10.1039/c4fd00247d. Epub 2015 May 5.

PMID:
25939489
35.

An experimental and computational study of the hydrodynamics of high-velocity water microdrops for interproximal tooth cleaning.

Rmaile A, Carugo D, Capretto L, Wharton JA, Thurner PJ, Aspiras M, Ward M, De Jager M, Stoodley P.

J Mech Behav Biomed Mater. 2015 Jun;46:148-57. doi: 10.1016/j.jmbbm.2015.02.010. Epub 2015 Feb 21.

PMID:
25792412
36.

The Role of Active Site Residues in ATP Binding and Catalysis in the Methanosarcina thermophila Acetate Kinase.

Ingram-Smith C, Wharton J, Reinholz C, Doucet T, Hesler R, Smith K.

Life (Basel). 2015 Mar 12;5(1):861-71. doi: 10.3390/life5010861.

37.

Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.

Cotroneo E, Ashek A, Wang L, Wharton J, Dubois O, Bozorgi S, Busbridge M, Alavian KN, Wilkins MR, Zhao L.

Circ Res. 2015 May 8;116(10):1680-90. doi: 10.1161/CIRCRESAHA.116.305265. Epub 2015 Mar 12.

38.

Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage.

Leclerc JL, Blackburn S, Neal D, Mendez NV, Wharton JA, Waters MF, Doré S.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1155-60. doi: 10.1073/pnas.1412833112. Epub 2015 Jan 12.

39.

α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlanders.

Wilkins MR, Aldashev AA, Wharton J, Rhodes CJ, Vandrovcova J, Kasperaviciute D, Bhosle SG, Mueller M, Geschka S, Rison S, Kojonazarov B, Morrell NW, Neidhardt I, Surmeli NB, Aitman TJ, Stasch JP, Behrends S, Marletta MA.

Circ Cardiovasc Genet. 2014 Dec;7(6):920-9. doi: 10.1161/CIRCGENETICS.114.000763. Epub 2014 Nov 4. Erratum in: Circ Cardiovasc Genet. 2015 Feb;8(1):244. Surmeli, Nur Basek [corrected to Surmeli, Nur Basak]. Circ Cardiovasc Genet. 2015 Feb;8(1):244.

40.

Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin.

Doroshenko N, Tseng BS, Howlin RP, Deacon J, Wharton JA, Thurner PJ, Gilmore BF, Parsek MR, Stoodley P.

Antimicrob Agents Chemother. 2014 Dec;58(12):7273-82. doi: 10.1128/AAC.03132-14. Epub 2014 Sep 29.

41.

miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia.

Iannone L, Zhao L, Dubois O, Duluc L, Rhodes CJ, Wharton J, Wilkins MR, Leiper J, Wojciak-Stothard B.

Biochem J. 2014 Aug 15;462(1):103-12. doi: 10.1042/BJ20140486.

PMID:
24895913
42.

Role of asymmetric methylarginine and connexin 43 in the regulation of pulmonary endothelial function.

Tsang H, Leiper J, Hou Lao K, Dowsett L, Delahaye MW, Barnes G, Wharton J, Howard L, Iannone L, Lang NN, Wilkins MR, Wojciak-Stothard B.

Pulm Circ. 2013 Sep;3(3):675-91. doi: 10.1086/674440. Epub 2013 Dec 4.

43.

Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension.

Wojciak-Stothard B, Abdul-Salam VB, Lao KH, Tsang H, Irwin DC, Lisk C, Loomis Z, Stenmark KR, Edwards JC, Yuspa SH, Howard LS, Edwards RJ, Rhodes CJ, Gibbs JS, Wharton J, Zhao L, Wilkins MR.

Circulation. 2014 Apr 29;129(17):1770-80. doi: 10.1161/CIRCULATIONAHA.113.006797. Epub 2014 Feb 6.

44.

Life under flow: A novel microfluidic device for the assessment of anti-biofilm technologies.

Salta M, Capretto L, Carugo D, Wharton JA, Stokes KR.

Biomicrofluidics. 2013 Dec 23;7(6):64118. doi: 10.1063/1.4850796. eCollection 2013 Dec 23.

45.

Anti-biofilm performance of three natural products against initial bacterial attachment.

Salta M, Wharton JA, Dennington SP, Stoodley P, Stokes KR.

Int J Mol Sci. 2013 Nov 4;14(11):21757-80. doi: 10.3390/ijms141121757.

46.

Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension.

Ruiter G, Lanser IJ, de Man FS, van der Laarse WJ, Wharton J, Wilkins MR, Howard LS, Vonk-Noordegraaf A, Voskuyl AE.

Rheumatology (Oxford). 2014 Feb;53(2):285-92. doi: 10.1093/rheumatology/ket331. Epub 2013 Oct 22.

PMID:
24155365
47.

Pulmonary hypertension: biomarkers.

Rhodes CJ, Wharton J, Wilkins MR.

Handb Exp Pharmacol. 2013;218:77-103. doi: 10.1007/978-3-642-38664-0_4. Review.

PMID:
24092337
48.

Characterisation of Crevice and Pit Solution Chemistries Using Capillary Electrophoresis with Contactless Conductivity Detector.

Nie M, Wharton JA, Cranny A, Harris NR, Wood RJK, Stokes KR.

Materials (Basel). 2013 Sep 30;6(10):4345-4360. doi: 10.3390/ma6104345.

49.

Clinical Implications of Bilirubin-Associated Neuroprotection and Neurotoxicity.

Mendez NV, Wharton JA, Leclerc JL, Blackburn SL, Douglas-Escobar MV, Weiss MD, Seubert CN, Doré S.

Int J Clin Anesthesiol. 2013 Sep-Oct;1(2). pii: 1013. Epub 2013 Sep 29.

50.

Marine biofilms on artificial surfaces: structure and dynamics.

Salta M, Wharton JA, Blache Y, Stokes KR, Briand JF.

Environ Microbiol. 2013 Nov;15(11):2879-93. doi: 10.1111/1462-2920.12186. Epub 2013 Jul 19. Review.

PMID:
23869714

Supplemental Content

Loading ...
Support Center